MAM
CNBC announces edition 6 of Managing India Brainstorm
MUMBAI: Managing India Brainstorm, the corporate forum which converges luminaries from diverse streams of industry and business will focus on the manufacturing sector in its the sixth session. Organised by business channel CNBC India in association with Wipro Infotech and Sun Microsystems, the forum will be held at Grand Hotel (Grand Hyatt) in Delhi on 9 January .
The Brainstorm will feature Jairam Ramesh (Economist), Gautam Thapar (BILT), Baba Kalyani (Bharat Forge), Suketu Shah (CII), Bobby Parikh (Ernst & Young) and Vallabh Bhansali (ENAM Securities) as initiators.
According to a release , the session will primarily focus on identifying the problem areas, bridging gaps between policy and on-ground realities, public-private partnerships and collaboration between the corporate sector and state governments to create and drive growth and also work towards development of a blueprint for growth in the present environment.
The forum envisaged to work towards creation of a balanced and comprehensive view of the state of India’s industry and economy held its first session in Mumbai. This was followed by sessions in other cities as well, adds the release.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
